Response to Gerard Chaouat: Primum Non Nocera.
Laboratory for Reproductive Medicine and Immunology, San Francisco, CA, USA. ewinger@sbcglobal.net
Edward E
EE
Winger
Jane L
JL
Reed
D000026:Abortion, Habitual / Q000188:drug therapy* / Q000276:immunology; D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D007167:Immunotherapy; D011247:Pregnancy; D018570:Risk Assessment
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab